Drug Shortage Report for DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML
Report ID | 136195 |
Drug Identification Number | 01934333 |
Brand name | DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML |
Common or Proper name | DEPO-MEDROL |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPREDNISOLONE ACETATE |
Strength(s) | 40MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL |
Packaging size | 5 X 5mL vial |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | |
Actual end date | 2023-04-03 |
Shortage status | Resolved |
Updated date | 2023-04-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2023-04-04 | English | Compare |
v15 | 2023-04-03 | French | Compare |
v14 | 2023-04-03 | English | Compare |
v13 | 2022-01-12 | French | Compare |
v12 | 2022-01-12 | English | Compare |
v11 | 2021-10-21 | English | Compare |
v10 | 2021-10-20 | French | Compare |
v9 | 2021-10-20 | English | Compare |
v8 | 2021-10-04 | French | Compare |
v7 | 2021-10-04 | English | Compare |
v6 | 2021-08-02 | French | Compare |
v5 | 2021-08-02 | English | Compare |
v4 | 2021-06-02 | French | Compare |
v3 | 2021-06-02 | English | Compare |
v2 | 2021-03-24 | French | Compare |
v1 | 2021-03-24 | English | Compare |
Showing 1 to 16 of 16